Nanocrine
1 known investors
Nanocrine develops plasmonic biosensor chips that enable real-time, label-free imaging of protein secretions from live cells using standard microscopes. The company serves cell biology researchers who need advanced quantitative detection of extracellular secretions for drug development and biological research.
BiotechDeep TechMedical Devices